Dermis disorder
MONDO:0021154A disease that involves the dermis.
Also known as: dermis disease, dermis disease or disorder, disease of dermis, disease or disorder of dermis, disorder of dermis, other dermis disorder
103 clinical trials for this condition and its sub-types, 0 tagged with Dermis disorder itself.
Follow this condition to get notified about new trialsWhere it sits in the disease tree
Browse by category →Part of
Sub-types of Dermis disorder
-
Dermis tumor 0 trials · 90 incl. sub-types
8 sub-types
- Malignant dermis tumor 0 trials · 87 incl. sub-types Sub-types →
- Leiomyoma cutis 2 trials Sub-types →
- Cutaneous fibrous histiocytoma 1 trial
- Cutaneous granular cell tumor 0 trials · 1 incl. sub-types Sub-types →
- Cutaneous mastocytosis 1 trial Sub-types →
- Skin glomus tumor 1 trial Sub-types →
- Angioma serpiginosum 0 trials Sub-types →
- Juvenile hyaline fibromatosis 0 trials
-
Primary cutaneous amyloidosis 4 trials · 5 incl. sub-types
5 sub-types
- Lichen amyloidosis 2 trials
- Familial primary localized cutaneous amyloidosis 1 trial Sub-types →
- Macular amyloidosis 1 trial
- Amyloidosis cutis dyschromia 0 trials
- Nodular cutaneous amyloidosis 0 trials
-
Primary anetoderma 4 trials
-
Mixed dermis disorder 0 trials · 3 incl. sub-types
6 sub-types
- Aplasia cutis congenita 3 trials Sub-types →
- Aplasia cutis congenita-intestinal lymphangiectasia syndrome 0 trials
- Linear skin defects with multiple congenital anomalies 0 trials Sub-types →
- Recessive aplasia cutis congenita of limbs 0 trials
- Scalp defects-postaxial polydactyly syndrome 0 trials
- Scalp-ear-nipple syndrome 0 trials
-
Elastoma 1 trial
-
Annular erythema of infancy 0 trials
-
Antecubital pterygium syndrome 0 trials
-
Atrophoderma of Pierini and Pasini 0 trials
-
Confetti-like macular atrophy 0 trials
-
Dermochondrocorneal dystrophy 0 trials
-
Elastoderma 0 trials
-
Elastosis perforans serpiginosa 0 trials
-
Familial anetoderma 0 trials
-
Familial cutaneous collagenoma 0 trials
-
Late-onset focal dermal elastosis 0 trials
-
Lichen myxedematosus 0 trials
3 sub-types
- Atypical lichen myxedematosus 0 trials Sub-types →
- Localized lichen myxedematosus 0 trials Sub-types →
- Scleromyxedema 0 trials
-
Linear atrophoderma of Moulin 0 trials
-
Linear focal dermal elastosis 0 trials
-
Lipoid proteinosis 0 trials
-
Mid-dermal elastolysis 0 trials
-
Necrobiosis lipoidica 0 trials
-
Papular elastorrhexis 0 trials
-
Primary cutis verticis gyrata 0 trials
3 sub-types
-
Progressive osseous heteroplasia 0 trials
-
White fibrous papulosis of the neck 0 trials
Most studied deeper sub-types
-
Can a new drug shrink Hard-to-Treat adrenal tumors?
Disease control Not yet recruitingThis phase 2 trial is testing whether the drug ivonescimab can help control advanced or metastatic adrenal cancers, specifically adrenocortical carcinoma (ACC) and pheochromocytoma/paraganglioma (PPGL), that have not responded to prior treatment. About 20 adults with these rare c…
Phase 2 • Sponsor: M.D. Anderson Cancer Center • Aim: Disease control
Last updated Sep 20, 2026 00:00 UTC
-
Can a smaller dose of this cancer drug still work? new trial aims to find out
Disease control Not yet recruitingThis phase 2 trial is testing whether a lower dose of the immunotherapy drug nivolumab, given less often, can still control cancer in people with various advanced or metastatic cancers. The goal is to see if a cheaper, more accessible regimen works as well as the standard high-co…
Phase 2 • Sponsor: Fred Hutchinson Cancer Center • Aim: Disease control
Last updated Sep 19, 2026 00:00 UTC
-
New combo aims to fight merkel cell cancer when immunotherapy fails
Disease control Not yet recruitingThis study tests whether combining two drugs—ASTX727 (a pill) and retifanlimab (given through a vein)—can shrink tumors and control advanced Merkel cell cancer in people whose disease has worsened after standard immunotherapy. About 31 adults with stage III or IV Merkel cell canc…
Phase 1/2 • Sponsor: University of Wisconsin, Madison • Aim: Disease control
Last updated Sep 04, 2026 00:00 UTC
-
Old drug, new hope: mercaptopurine tested against rare cancer syndrome
Disease control Not yet recruitingThis trial tests the drug mercaptopurine in people with hereditary leiomyomatosis and renal cell carcinoma (HLRCC), a rare genetic condition that raises the risk of skin, uterine, and kidney tumors. The study aims to find the safest dose and see if the drug can shrink kidney canc…
Phase 1 • Sponsor: Jonsson Comprehensive Cancer Center • Aim: Disease control
Last updated Aug 08, 2026 00:03 UTC
-
Can Platelet-Rich plasma boost microneedling for skin amyloidosis?
Symptom relief Not yet recruitingThis study tests whether adding platelet-rich plasma (PRP) to microneedling improves itching and dark patches in macular amyloidosis better than microneedling alone. Thirty adults with the condition will have each side of their face treated differently, and results will be checke…
Sponsor: Cairo University • Aim: Symptom relief
Last updated Jun 27, 2026 08:12 UTC